Related by context. All words. (Click for frequent words.) 61 FINANCIAL RISK MANAGEMENT 60 Tst 60 Content Outline 60 Ownership Structure 59 Second Quarter Highlights 59 Anworth Announces 59 Condensed Cash Flow 58 Half Yearly Accounts 58 Cash Flow Statement 58 PPD Declares 58 SHIRE PLC 58 GBP'# GBP'# GBP'# GBP'# 58 Factors Impacting 58 Half Yearly Report 58 Appendix 4E 58 AQUARIUS PLATINUM LIMITED 58 GBP#.# Million [001] 58 GBP'# GBP'# GBP'# 57 XPEL Announces 57 Exceptional Items 57 DWS RREEF 57 Segment Highlights 57 Consolidated Condensed Statement 57 Reviewed Reviewed 57 OVERVIEW OF 57 I. INTRODUCTION 57 KEY FIGURES 57 DJ EANS Adhoc 57 ACCOUNTING POLICIES 57 Operational Highlights 56 Publicly Held 56 Guidance Reaffirmed 56 GBP'# 56 Financing Costs 56 Funds Announce 56 -Carl Kieke 56 Miscellaneous #.#.# Release 56 Imports Exports 56 MANAGEMENT DISCUSSION AND ANALYSIS 56 CDATA pre 56 Currency Fluctuations 56 APA ots news 56 CORPORATE GOVERNANCE STATEMENT 56 #.#.# Ad hoc 56 TRUST PLC 56 LECTRA 55 Diversified Portfolio 55 [017] 55 FINANCIAL OVERVIEW 55 Director Shareholding 55 Directors Dealings 55 TELEPERFORMANCE 55 Segmental 55 Condensed consolidated 55 CONSOLIDATED FINANCIAL STATEMENTS 55 SYNAXON AG 55 Pro Forma Results 55 E.1 55 Activity Slows 55 Amvescap PLC UK 55 Amount Amount 55 Funds Declare Quarterly 55 Commence Phase 55 Strengthen Balance Sheet 55 Allbanc Split Corp. 55 Goodwill Impairment 55 Appendix 4D 55 Competitive Scenario 55 Protherics PLC announces 54 GBP#.# Billion [001] 54 #Q# Earnings Release 54 VCT plc 54 Triplan AG 54 Solvency II Basel 54 Nonqualified Deferred Compensation 54 Regulatory Announcement 54 SEK -#.# -#.# [002] 54 Upward Revision 54 SIGNIFICANT ACCOUNTING POLICIES 54 Acquires Minority 54 Further Cautionary Announcement 54 CORPORATE INFORMATION 54 #,#.# #,#.# [008] 54 Statutory Accounts 54 Gastric Cancer 54 Estimated NAV 54 Non Gaap 54 Gross Premiums Written 54 Material Fact 54 Ownership Interests 54 Balance Sheet Cash Flow 54 Randomized Clinical Trials 54 Appendix 4C 54 MISYS PLC 54 Appendix 4E Preliminary 54 CAPITAL EXPENDITURE 54 GBPm GBPm GBPm GBPm 54 ATTACHMENT 54 Plaut Aktiengesellschaft 54 SABESP Announces 54 BIOLASE Announces 54 Previous Corresponding Period 54 BasWare Corporation 54 CALAMOS 54 PremierWest Bancorp Announces 54 Connected Transactions 54 Funds Declare Monthly Distributions 54 CorVel Announces 54 -Ganga aarti 54 Third Quarter Dividend 54 Satellite Transponders 54 GAAP Adj 54 Thromb Haemost 54 Legal #.# 54 Sentiment Improves 53 Therapeutic Monoclonal Antibodies 53 Multicenter Phase 53 EXECUTIVE SUMMARY 53 Dividend Declaration 53 Therapeutic Competitors Report 53 SPECIAL BUSINESS 53 Heliad Equity Partners 53 Nasdaq IIVI 53 Wtd 53 Qrtr 53 Pract 53 RELATED PARTY TRANSACTIONS 53 Product Introductions Innovations 53 KEMIRA 53 AND SUBSIDIARIES SEGMENT REPORTING 53 HKSE HYSNY.PK 53 Regular Quarterly 53 unaudited Consolidated Statements 53 Takeover Bids 53 Inc. LATEST NEWS 53 Pro Rata 53 RISKS AND UNCERTAINTIES 53 RECENT INDUSTRY ACTIVITY 53 MARKET OUTLOOK 53 ATOSS Software AG 53 Items Affecting Comparability 53 Flagstone Re Announces 53 Hematological Cancers 53 Puma VCT 53 Guidelines Issued 53 Unaudited Interim 53 SoftM AG 53 CanTex Energy Corp. 53 PRESS RELEASE Fitch Downgrades 53 Maintenance Capital Expenditures 53 unaudited unaudited audited 53 HAHN Immobilien Beteiligungs AG 53 - Non GAAP [031] 53 TABLE OF CONTENTS 53 Competitive Scenario II 53 INTERIM FINANCIAL STATEMENTS 53 http:/hugin.info/#/R/#/#.pdf [001] 53 -Tyrell Fenroy 53 OPENLiMiT Holding AG 53 Period Ending 53 APPENDIX 53 Quarterly Dividends 53 Technol 53 Table Follows 53 Process Automation Solution 53 Comprehensive Overview 53 Cashflow Report 53 Equity Fixed Income 53 Invesment 53 EUR# Billion 53 EUR1 Billion 53 Growth Exceeds Expectations 53 Altor Fund 53 COMPANY CONSOLIDATED INCOME STATEMENTS 53 OTHER MATTERS 53 Audited Results 53 NASDAQ IIVI 53 [006] 53 FINANCIAL STATEMENTS 53 Dividend Rate 52 Gap Widens 52 Continues Upward Trend 52 FINANCIAL REPORT 52 Medoro Resources Announces 52 Appendix 4D Half 52 ANNUAL REPORT 52 Equity Funds Declare 52 OF NON GAAP MEASURES 52 Wholly Owned 52 Financing Arrangement 52 EMEA Subsidiaries 52 Warrants Exercised 52 Concluding Remarks 52 PRC Accounting Standards 52 Supplemental Non GAAP 52 Confidence Rises 52 Trend Towards 52 Quintek Technologies 52 Hedge Fund Replication 52 Non Recurring 52 Ltd SGM 52 Topics Covered Executive 52 Kaydon Corporation Announces 52 Declares Dividend Quick Facts 52 Dividend Payment 52 INTRODUCTION I. 52 YEAR ENDED 52 Dividend Payout 52 Net Tangible Assets 52 SEE ATTACHED 52 .execute arbitrary SQL 52 INFRASTRUCTURE FUND 52 Distributions Paid 52 Mln Euros 52 Bladex Announces 52 DIRECTORS REPORT REMUNERATION REPORT 52 #,#,#,# #,#,#,# #,#,#,# 52 IFRS IFRS 52 Vitality Re 52 Weightings 52 ANNUAL FINANCIAL REPORT 52 GROWTH FUND 52 Rs.#.# Crores [001] 52 Eur J Cancer 52 Obtains Financing 52 Newsflashes 52 -Cedomir Jovanovic 52 Achieves CMMI Level 52 J Clin Endocrinol Metab 52 Sequential Quarterly 52 Clinical Outcome 52 Curr Opin 52 Preferred Stock Dividend 52 FOCUS ON SELECT PLAYERS 52 Brief Introduction 52 SEGRO plc 52 Entered Into 52 #Q# #Q# Var 52 Zhaikmunai LP 52 EUR#.#.# 52 Consolidated Cash Flows 52 Load Structure 52 Normalized EBIT 52 AvalonBay Communities Announces 52 Spending Rises 51 overname 51 Typhoid Vaccine 51 .W. McNichols 51 REAL ESTATE BUSINESS 51 Trapeza 51 [004] 51 -mother Arndrea 51 Confidence Plunges 51 CAPITAL LIMITED 51 AUDITED 51 Confirmatory Phase 51 BUSINESS OPERATIONS 51 -#,# -# 51 Medicure Announces 51 SECOND GUIDE TO 51 END USE 51 Confidence Improves 51 Biol Psychiatry 51 Stent Placement 51 Ticker Symbol Change 51 Grantor Trust 51 FINAL REPORT 51 IVQ 51 Mechel Announces 51 Organizational Structure 51 -agriculture Renson Gasela 51 Jointly Owned 51 Underlie 51 Coated Fabrics 51 Cash Flows Used 51 Annu Rev 51 H1 FY 51 LP# [001] 51 Table SECTION 51 Half Yearly 51 ACCLAIM COPD 51 Inorganic Chemicals 51 Financial Intermediation 51 Pl. 51 CICA Accounting Guideline 51 Ixis Asset Management 51 OKO Bank plc 51 STATE STREET CORPORATION 51 Condensed Consolidated Interim 51 bmp AG 51 NON AUDIT SERVICES 51 AG deutsch 51 Acquires Controlling Interest 51 Psychosom Med 51 Plumas Bancorp Reports 51 Supplementary Data 51 Milestone Achieved 51 Wachstum 51 Compulsory Licensing 51 CAPITAL TRUST 51 Osteoarthritis Pain 51 Comparative Figures 51 Restatement Process 51 YM BIOSCIENCES INC. 51 Ann Rheum Dis 51 APPENDIX 4D 51 Navios Aurora 51 Interest Coverage Ratio 51 Fixed Income Derivatives 51 weighted avg 51 Arch Neurol 51 Randomized Double Blind Placebo 51 INVESTMENTS LIMITED 51 -Amneal Pharmaceuticals LLC 51 A.Market Analysis 51 NOTICE OF MEETING 51 restated restated 51 Retains CCG Elite 51 Gerdau Ameristeel Announces 51 Investig 51 Decorative Laminates 51 InStorage REIT Announces 51 Canned Soups 51 increaseof 51 Pivotal Phase II 51 PENN NATIONAL GAMING 51 Funds Declare Monthly Dividends 51 Closes Oversubscribed 50 Susceptibility Testing 50 Dividend Distribution 50 ZAE # 50 PetroMENA ASA 50 Suomen Terveystalo Oyj 50 unaudited consolidated balance sheets 50 Microbiol 50 MEDIA LIMITED 50 Adjust Adjusted 50 GOL Announces 50 Confidence Declines 50 Growth Oriented 50 Market Disruption 50 Competitive Scenario III 50 Improving Efficiency 50 Interv 50 Adipic Acid 50 TAG Tegernsee Immobilien und 50 WITHDRAWAL OF CAUTIONARY ANNOUNCEMENT 50 Lung Cancer Trial 50 ElringKlinger AG 50 Denominated 50 Reduces Cost 50 Wkly 50 BQT Satellites 50 Derivative Transactions 50 Dividend Dates 50 Statin Drugs 50 Dose Ranging 50 Wholly Owned Subsidiaries 50 Multicap Fund 50 Remium AB 50 USGAAP 50 ACCOUNTING STANDARDS 50 :5 50 Code # 50 Biosensor Technology 50 GRAS Status 50 Filing Status 50 Raiffeisen Zentralbank Österreich AG 50 Debt Obligations 50 Tangible Equity 50 Various Types 50 Inve 50 First BanCorp Announces 50 LEAGUE DIVISION 50 J Pediatr 50 EQUITY RESIDENTIAL 50 Valorisation 50 Appendix 4D item 50 Identification Number ISIN 50 Fourth Quarter Dividend 50 Recent Accounting Pronouncements 50 #.#c #.#c [006] 50 By Denes Husty 50 Chart Presentation 50 Clin Oncol 50 Smooth Muscle 50 Reputational Risk 50 GrowthPlus 50 WESTWOOD ONE INC. SUPPLEMENTAL 50 COMMERZBANK 50 HALF YEAR REPORT 50 LUCENT TECHNOLOGIES INC. AND 50 Non Dilutive 50 Integr 50 -ruminant animal 50 Negative Impact 50 Gastrointestinal Disorders 50 Transition Period 50 Norcraft Holdings 50 Opportunities Exist 50 Comprises 50 Arch Dermatol 50 Rheumatol 50 Controlled Entity 50 Signs Merger Agreement 50 Polyester Fiber 50 shaPE Capital AG 50 Mol Med 50 Patents Issued 50 Cropredy Res 50 Proposed Private Placement 50 Accts 50 Non IFRS 50 NZX Listing Rules 50 Guidance Assumptions 50 + - [002] 50 Comparative Condensed Consolidated Statements 50 Sublicense 50 INTERIM REPORT 50 Regulatory Developments 49 Topics Covered I. INTRODUCTION 49 Crowflight Announces 49 Mondi Hadera Paper 49 Statistical Tables 49 Downing Protected VCT 49 I. INTRODUCTION METHODOLOGY 49 Mickleton Rgrs 49 Double Digit Increase 49 Polyester Staple Fiber 49 Non GAAP Measure 49 Pediatr 49 Cash Flow Statements 49 BENCHMRK 49 CAPITAL ACCOUNT 49 EZTEC Empreendimentos e 49 -validated Borel 49 CNinsure Announces 49 B.V. 49 Euro Trades Near 49 - - Net [047] 49 Consolidated EBITDAR 49 PRIVATE BANKING 49 -Genereaux 49 CELGENE 49 Conversion Ratio 49 Income Tax Regs 49 Capitalised 49 financialstatements 49 Study Shows Benefits 49 Diabetes Res Clin 49 Interest Rate Derivatives 49 ANNEXURE 49 Adjusted EBIT 49 FIRST DATA CORPORATION 49 Notice Regarding 49 CitiWarrants 49 Randomized Study 49 -ABGL 49 Observational Studies 49 Y Y -#.# 49 Debt Restructure 49 PRODUCT DISCLOSURE STATEMENT 49 = Operaanalytic geometry 49 AND CONTROLLED ENTITIES 49 Parent Entity 49 ISRAEL LTD 49 Disclosure Requirement 49 Measurement Specialties Announces 49 Qtr Ended 49 SOLON AG für Solartechnik 49 Sentiment Rises 49 INC. Supplemental 49 CONTINUING CONNECTED TRANSACTIONS 49 Notional Amount 49 Study Proves 49 #.#-# b [001] 49 Reference Document 49 Guidelines Recommend 49 .cagy veteran 49 AUDIOCODES LTD 49 Singapore Bourse Change 49 totaled RUB 49 constitutes discloseable transaction 49 Analytical Tool 49 Normalized EBITDA 49 Crop Cultivation 49 uncertificated registered 49 FEIM 49 信托 49 Smallcaps 49 #/#/# #/#/# - [002] 49 Mergers Acquisitions Takeovers 49 Vantex Completes 49 GROUP PLC 49 Macro Trends 49 Emerging Mkts 49 CREDIT AGRICOLE 49 Normalized Earnings 49 Azithromycin Dispersible Tablets 49 WILEX AG 49 CORPORATE DIRECTORY 49 TB Vaccine 49 NO BANK GUARANTEE 49 Financial Holding TWSE 49 GROUP LIMITED ABN 49 Urol 49 BNS Split Corp. 49 Alison Bevege 49 Shareholdings 49 VI Incorporated 49 Lagercrantz Group 49 GAAP RATIOS 49 FASEB J. 49 Structural Changes 49 Pub. 49 #.# #.# [005] 49 BOVESPA AMIL3 49 EANS 49 Biz Briefing 49 mn Yen YY 49 SMARTREND NEWS 49 Orthopedic Implants 49 Negotiation Strategies 49 Constitutes 49 THE OFFER .oriental spices 49 Therapeutic Approaches 49 Expert Opin 49 Portfolio Diversification 49 Cash Distributions 49 Menopausal Symptoms 48 Default Risk 48 -Horntvedt 48 Longer Term 48 Derivatives Risk 48 Double Blind Randomized 48 CFR #.#b 48 Publicly Traded Companies 48 Reaffirms FY 48 Competitive Advantages 48 BALANCE DATE 48 Previously Announced Private Placement 48 CHF#.#B 48 Epilepsy Drug 48 DEALINGS BY 48 Antiepileptic Drug 48 Cautionary Notes 48 Renal Tumors 48 Unaudited Condensed Consolidated 48 CEAG AG 48 II MARKET ENVIRONMENT 48 WPHG 48 WpUG 48 VCEG 48 Defined Benefit Plans 48 Market Stabilizes 48 RM#.# Mln 48 #Table [003] 48 Proxy Voting 48 www.omxgroup.com 48 Different Types 48 zum Mitteilungspflichtigen = 48 Collateralised 48 Toxicol 48 INTESA SANPAOLO 48 Successor Depositary Bank 48 Randomized Controlled Trials 48 Synthetic CDO 48 ps :# 48 Ann Intern Med 48 Suppl. 48 Anonyme 48 Condensed Consolidated Cash Flow 48 IDS Holders 48 PDS PDS 48 Randomized Placebo Controlled Trial 48 Long Term Outcomes 48 :2 48 NOT FDIC NCUA 48 EXPLANATORY MEMORANDUM 48 Abraaj Buyout Fund 48 Diagnostic Radiopharmaceuticals 48 Ltd ACN 48 Acne Treatments 48 J Endocrinol 48 Nat Genet 48 und sowie 48 Cardene R 48 Orthop Surg 48 -Lake Andrusia 48 By DENES HUSTY 48 JSC SITRONICS 48 Acadia Realty 48 L imited 48 Practical Implications 48 Ordinary Dividends 48 Limited HKG 48 Ltd #.SZ 48 Holdings Ltd SGM 48 Amount Amount Amount 48 PIMCO Municipal Income 48 Luthai Textile Co 48 -Dariusz Snarski 48 Study Compares 48 Luna Innovations Announces 48 PARAGRAPH 48 Performance Incentive Plan 48 + Medien AG 48 Probably Slowed 48 Breast Cancer Incidence 48 Initiated Phase 48 Antipsychotic Drugs 48 semestre 48 BioElectronics Announces 48 Clinically Tested 48 Allomak Limited 48 Physiol 48 -Apparel Fabrics 48 Drybulk Vessel 48 Betaferon R 48 Spin Offs 48 Pharmacologic Treatment 48 Summary Table 48 Trapeza CDO 48 Sponda Oyj 48 Disord 48 Adjuvant Treatment 48 InterRent REIT Announces 48 #-# Full Text 48 Scrip Dividend Programme 48 SearchMedia Holdings Limited 48 Inkjet Inks 48 Flexpoint Announces 48 BioElectronics Corporation Announces 48 Erectile Dysfunction Drug 48 Accounting Policies 48 Cholinesterase Inhibitors 48 Surgical Procedure 48 Alphaform AG 48 ADR RevPAR 48 WebTech Wireless Announces 48 ID nBOM# [002] 48 Protein Synthesis 48 operatingincome 48 C.1 48 Suppl 48 NJSA 2C :5 48 TOP Ships Announces 48 Rate Climbs 48 Raw #/#/# Punjab 48 Andina Minerals 48 Providing Valuable 48 Appendix 5B 48 Symptom Relief 48 Corporate Governance Statement 48 prgms 48 By Linwood Outlaw 48 LSV Asset Management 48 Counterparty Criteria 48 J Affect Disord 48 Obes Res 48 Listing Rule #.#A 48 De Minimis 48 Vasc 48 Critical Elements 48 Oral Fingolimod 48 Shows Efficacy 48 Segmented Results 48 Issues Confronting 48 Largest Database 48 Consolidated Condensed Financial 48 Disclosure Requirements 48 Kilroy Realty Declares Quarterly 48 Ann Oncol 48 POWER SECTOR ASSETS 48 :7 48 - -Witness Maurice Brighthaupt 48 Cheung Kong Holdings HKSE 48 Roth IRA Conversions 47 Relation Between 47 Regulatory Regime 47 Inks MOU 47 Neurol 47 Randomized phase 47 Counterparty Risk Management 47 Proposed Revisions 47 Scand J 47 AND REGULATION 47 Canara Robeco Balance 47 ZoomMed inc 47 Blackrock Muni 47 Semester Examination 47 PLC FRN Variable 47 Oral Session 47 PerkinElmer Acquires 47 Eldest Inheritance Book 47 BANCOLOMBIA 47 Majority Shareholder 47 - Revenues [003] 47 interim condensed consolidated 47 Defined Terms 47 Lowers Risk 47 WpHG mit dem Ziel 47 FUND Consolidated Statements 47 Eur Respir J 47 Sciens 47 PROFILE OF 47 CBOT Soy Outlook 47 ALASKA COMMUNICATIONS SYSTEMS GROUP 47 Corporate Governance Principles 47 -Unprovoked 47 Siemens Aktiengesellschaft 47 Randomized Clinical Trial 47 Latent Demand 47 Genetic Defect 47 Supplemental Schedule 47 Adverse Event 47 Debt Repayment 47 Formulates 47 Clin Trials 47 Price Inflation Slows 47 Cancer Res 47 - -Vader costume 47 NIS #.#b [002] 47 Oleochemicals 47 Convertible Subordinated 47 IAS IFRS 47 Booster Shot 47 Actively Managed ETFs 47 Occupational Pension Schemes 47 Heiler Software 47 SHAREHOLDING 47 Ojsc 47 Randomized Phase II 47 Ticker Symbols 47 Strategic Rationale 47 Chartpoppers.com releases 47 FDA Okays 47 patrick.graham @ thomson.com 47 # - -Muscoda 47 AMVISC ® AMVISC ® 47 Items Impacting Comparability 47 Buys Majority Stake 47 Spinal Manipulation 47 Audited Annual 47 Free Full Text 47 J Orthop 47 Confidence Rebounds 47 Pooled Fund 47 Primary Efficacy Endpoint 47 Pöyry PLC 47 Summary RECONCILIATION OF 47 AT# [004] 47 Month Euribor 47 zu entwickeln 47 Reclassified 47 분수대 47 Data Disappoints 47 Resource Utilization 47 Parathyroid Hormone 47 UPCB Finance 47 Diabet Med 47 Significant Improvements 47 Managements Discussion 47 Glb 47 Pl. s 47 Quick Primer 47 eBulletin 47 CBOT Corn Outlook 47 PF LUX 47 Kommunalkredit Austria AG 47 Commonly Used 47 + - + - [009] 47 Altamir Amboise 47 XS# [003] 47 Regular Monthly Distributions 47 J Urol 47 +#- 0 #-# [001] 47 Resale Registration Statement 47 accompanying condensed consolidated 47 Quarterly Activities 47 - + [020] 47 Accrued Payroll 47 Confidence Indicator 47 Consecutive Years 47 Adverse Reactions 47 Takeovers Regulations 47 Evinix Accessories 47 Mol Psychiatry 47 MiFID PCI GLBA 47 Blood Pressure Medication 47 Scrip Dividend Scheme 47 Mindax Limited 47 Outsourcing Contracts 47 LIMITED DIRECTORS REPORT 47 FAR #.#-# Evaluation 47 Consolidated Cash Flow 47 Selected GAAP Measures 47 GWB Immobilien AG 47 AB publ STO 47 LIST OF TABLES Table 47 Neurobiol 47 #:# -# [005] 47 Novavisions 47 # Chullora Equity 47 [013] 47 Folding Cartons 47 Topline Results 47 Bought Deal Financing 47 Infect Dis 47 Clinical Practice Guideline 47 Amounts Announced 47 ICVC 47 Cholesterol Drugs 47 Reacquisition 47 abstr 47 Announces Debt Settlement 47 Confidence Drops 47 Wereldhave NV 47 Large Diameter Pipe 47 Gynecol Oncol 47 Huaxin Cement Co 47 condensed consolidated 47 Prevent Stroke 47 Sensitivity Analysis 47 § #.#-# [007] 47 Skin Care Line 47 Guizhou LLF 47 GBP# GBP# [001] 47 -Claire Penhallurick 47 NextEconomy segment 47 Metabolic Disorder 47 Accelerating Growth 47 Muni Fd 47 Reduces Risk 47 Survival Rate 47 Companhia De 47 Multiple SQL Injection 47 -Richard Gitlen 47 Wholesale Leathercraft 47 Board FASB Accounting 47 Injectable Drug 47 Regulations Affecting 47 Holdco LLC 47 - -Crazyhorse 47 Near Infrared Optics 47 controlled multicenter Phase 47 Blood Glucose Meters 47 Expert Discusses 46 Antiviral Therapy 46 GASB Issues 46 Systemically Important 46 Taxability 46 GLOSSARY 46 GM Repays 46 EVLI 46 J Biol 46 Fytokem 46 Clarification Regarding 46 CapMan Buyout 46 DISCUSSION AND POSSIBLE APPROVAL 46 Intravenous Equipment 46 See Attachment 46 Becomes Easier 46 J Allergy Clin 46 :8 46 Unaudited Pro Forma 46 Splendid Medien AG 46 Regulatory Requirements 46 Immediate Effect 46 RMB#.# [006] 46 #.#-# Instructions 46 Continuous Disclosure Policy 46 Trends Affecting 46 FLY Leasing 46 Specified Items 46 Negatively Affect 46 amorti 46 DZ BANK AG 46 Geriatr 46 See id 46 Psychological Effects 46 Condensed Statement 46 J Child Adolesc 46 KeyLink Systems Distribution 46 Actively Seeking 46 Contrast Agents 46 Bluegrass ABS CDO 46 Subsidiaries Table 46 -leukemias 46 unaudited Consolidated Statement 46 Preliminary Findings 46 Molecular Mechanism 46 Iron Sucrose 46 doi #.# 46 Hybrid Capture 46 Cash Flow Margin 46 Prolongs Life 46 Common Pitfalls 46 Certifications Commercial Items 46 Statutory Accounting Principles 46 STOCK BASED COMPENSATION EXPENSE 46 Maternity Cover 46 Biol Phys 46 BY FRANK RADOSEVICH 46 Stent Restenosis 46 Healthcare REIT 46 Sàrl 46 Non GAAP Disclosures 46 Dramatic Increase 46 Annex Notification 46 zur und 46 Multicurrency 46 DSM NeoResins 46 FRESENIUS 46 Headwaters Incorporated Announces 46 B.3 46 Indexed Annuities 46 SPDS dated 46 CONTINGENCIES 46 WORKING GROUP 46 WELLS FINANCIAL CORP. 46 x denotes seeding 46 A.2 46 NON GAAP MEASURES 46 Original Bidder Statement 46 Adult Incontinence 46 Three Month Periods 46 Maleic Anhydride 46 Phytosterol 46 OAO WGC 46 Psychiatr Serv 46 FDA Warns Against 46 -Lynnae McCoy 46 Keywords MARKETS HONGKONG STOCKS 46 Hardwoods USLP 46 FAR #.#-# Offeror Representations 46 http:/hugin.info/#/R/#/#.pdf [002] 46 LIST OF TABLES 46 Cognitive Impairment 46 HOLDING LTD 46 NATIXIS 46 NOTIFICATION OF MAJOR INTEREST 46 Hornbach Baumarkt AG 46 Segment Margin 46 Engages CHF Investor Relations 46 CONFINDUSTRIA 46 LUCAS L. JOHNSON 46 Quarterly Interval Plan 46 Purchasing Patterns 46 Floor Bangunan 46 Oral Cavity 46 Product Monograph 46 adjusted ebitda 46 ICICI Pru MF 46 William F. Shughart 46 Pro forma Adjusted EBITDA 46 .PokerStars EPT 46 POLIS Immobilien AG 46 Has Been Awarded 46 Accenture SCA 46 Keywords MARKETS STOCKS 46 Taberna Preferred Funding 46 DEUTZ AG 46 Statutory Auditor 46 hGH CTP Phase 46 -organic yerba mate 46 Nephrol Dial Transplant 46 BY RICH MCCRACKEN 46 Non GAAP Measurements 46 Fracture Risk 46 REMUNERATION REPORT 46 Lowers Blood Pressure 46 Private Placement Closed 46 Endnotes 46 Compl 46 Nera Telecommunications 46 Obligor 46 e# e# [003] 46 Deteriorate 46 Apparel NASDAQ GIII 46 Brief Description 46 Structured Finance Transactions 46 Arch Intern Med 46 Recapitalisation Proposal 46 -tiger muskies 46 Levels Linked 46 Endocrinol 46 Dosage Forms 46 M anagement 46 Pricing Supplement 46 Trends Shaping 46 #,#,#.# #,#,#.# 46 Actively Managed ETF 46 Retention Rates 46 Rule #.#A 46 Westpac SPS 46 Genetically Engineered Animals 46 Online Drugstore 46 Infraserv